Parallax Volatility Advisers’s BioMarin Pharmaceuticals BMRN Stock Holding History

Parallax Volatility Advisers’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-28,200	Closed	-$1.85M	–	1608
2024 Q4	$1.85M	Buy	+28,200	New	+$1.89M	﹤0.01%	1149
2024 Q3	–	Sell	-18,500	Closed	-$1.52M	–	2031
2024 Q2	$1.52M	Buy	+18,500	New	+$1.54M	﹤0.01%	1125
2023 Q4	–	Sell	-41,500	Closed	-$3.67M	–	2190
2023 Q3	$3.67M	Buy	41,500 +41,000	+8,200%	+$3.65M	0.01%	884
2023 Q2	$43.3K	Hold	500	–	–	﹤0.01%	2088
2023 Q1	$48.6K	Sell	500 -24,500	-98%	-$2.54M	﹤0.01%	2219
2022 Q4	$2.59M	Hold	25,000	–	–	﹤0.01%	1305
2022 Q3	$2.12M	Hold	25,000	–	–	﹤0.01%	1403
2022 Q2	$2.07M	Hold	25,000	–	–	﹤0.01%	1331
2022 Q1	$1.93M	Buy	+25,000	New	+$2.09M	﹤0.01%	1380
2019 Q4	–	Sell	-1,800	Closed	-$122K	–	2428
2019 Q3	$122K	Sell	1,800 -83,200	-98%	-$6.41M	﹤0.01%	1944
2019 Q2	$7.28M	Buy	85,000 +31,500	+59%	+$2.69M	0.01%	605
2019 Q1	$4.75M	Buy	53,500 +13,500	+34%	+$1.25M	0.01%	708
2018 Q4	$3.41M	Buy	+40,000	New	+$3.81M	﹤0.01%	846
2016 Q1	–	Sell	-13,000	Closed	-$1.36M	–	2527
2015 Q4	$1.36M	Buy	+13,000	New	+$1.36M	﹤0.01%	1157
2014 Q2	–	Sell	-30,000	Closed	-$2.05M	–	4045
2014 Q1	$2.05M	Buy	+30,000	New	+$2.21M	0.01%	580

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Parallax Volatility Advisers's BMRN Position: Q2 2025 in Review

Parallax Volatility Advisers sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2025, closing a stake of 14,133 shares — an estimated $832K sold.

Parallax Volatility Advisers first reported a position in BMRN in Q1 2014 and held it in 18 quarters. The position peaked at $2.54M in Q2 2019. 581 funds tracked by Wall St. Rank hold BMRN as of Q2 2025.

Parallax Volatility Advisers reported no remaining BioMarin Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Parallax Volatility Advisers sold 14,133 BioMarin Pharmaceuticals shares in Q2 2025, an estimated $832K.
Parallax Volatility Advisers first reported a position in BioMarin Pharmaceuticals in Q1 2014 and held it in 18 quarters.
Parallax Volatility Advisers's BioMarin Pharmaceuticals position peaked at $2.54M in Q2 2019.
581 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2025.

Based on Parallax Volatility Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.